ES2168076B2 - Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion. - Google Patents

Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion.

Info

Publication number
ES2168076B2
ES2168076B2 ES200002094A ES200002094A ES2168076B2 ES 2168076 B2 ES2168076 B2 ES 2168076B2 ES 200002094 A ES200002094 A ES 200002094A ES 200002094 A ES200002094 A ES 200002094A ES 2168076 B2 ES2168076 B2 ES 2168076B2
Authority
ES
Spain
Prior art keywords
biopurification
activity
lactic acid
bacteria
new preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200002094A
Other languages
English (en)
Other versions
ES2168076A1 (es
Inventor
Tadayo Hata
Toshiyuki Maruoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BHPH Co Ltd
Original Assignee
BHPH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP05719399A priority Critical patent/JP4193269B2/ja
Priority to CA002314775A priority patent/CA2314775C/en
Priority to AU48966/00A priority patent/AU4896600A/en
Priority to GB0018956A priority patent/GB2365444B/en
Priority to US09/631,388 priority patent/US6333188B1/en
Priority to NL1015933A priority patent/NL1015933C2/nl
Priority to ES200002094A priority patent/ES2168076B2/es
Application filed by BHPH Co Ltd filed Critical BHPH Co Ltd
Priority to FR0010769A priority patent/FR2813084B1/fr
Priority to CNB001262033A priority patent/CN1160085C/zh
Priority to RU2000122386/13A priority patent/RU2186575C2/ru
Priority to BR0005049-0A priority patent/BR0005049A/pt
Priority to DE10042625A priority patent/DE10042625A1/de
Publication of ES2168076A1 publication Critical patent/ES2168076A1/es
Application granted granted Critical
Publication of ES2168076B2 publication Critical patent/ES2168076B2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/127—Clearans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nueva preparación de bacterias de ácido láctico con actividad de biopurificación, que comprende células viables de Lactobacillus clearans y tanto células viables como células muertas de Enterococcus faecalis, capaz de reducir uno o más de al menos triglicéridos y colesterol.
ES200002094A 1999-03-04 2000-08-17 Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion. Expired - Fee Related ES2168076B2 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP05719399A JP4193269B2 (ja) 1999-03-04 1999-03-04 新規な生体浄化活性型乳酸菌製剤
CA002314775A CA2314775C (en) 1999-03-04 2000-07-31 Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
AU48966/00A AU4896600A (en) 1999-03-04 2000-08-01 Novel lactic acid bacteria preparation having biopurification activity
GB0018956A GB2365444B (en) 1999-03-04 2000-08-02 Novel lactic acid bacterial preparation having biopurification activity
US09/631,388 US6333188B1 (en) 1999-03-04 2000-08-03 Lactic acid bacteria preparation having biopurification activity
NL1015933A NL1015933C2 (nl) 1999-03-04 2000-08-14 Nieuw melkzuurbacteriÙnpreparaat met biozuiveringsactiviteit.
ES200002094A ES2168076B2 (es) 1999-03-04 2000-08-17 Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion.
FR0010769A FR2813084B1 (fr) 1999-03-04 2000-08-21 Preparation de bacteries lactiques ayant une activite de biopurification
CNB001262033A CN1160085C (zh) 1999-03-04 2000-08-24 具有生物净化活性的乳酸菌制剂
RU2000122386/13A RU2186575C2 (ru) 1999-03-04 2000-08-24 Новый препарат молочнокислых бактерий со свойствами биологической очистки (варианты)
BR0005049-0A BR0005049A (pt) 1999-03-04 2000-08-25 Novo preparado de bactéria de ácido lático tendo atividade de biopurificação
DE10042625A DE10042625A1 (de) 1999-03-04 2000-08-30 Milchsäurebakterien-Präparat mit Aktivität zur biologischen Reinigung

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP05719399A JP4193269B2 (ja) 1999-03-04 1999-03-04 新規な生体浄化活性型乳酸菌製剤
CA002314775A CA2314775C (en) 1999-03-04 2000-07-31 Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
AU48966/00A AU4896600A (en) 1999-03-04 2000-08-01 Novel lactic acid bacteria preparation having biopurification activity
GB0018956A GB2365444B (en) 1999-03-04 2000-08-02 Novel lactic acid bacterial preparation having biopurification activity
US09/631,388 US6333188B1 (en) 1999-03-04 2000-08-03 Lactic acid bacteria preparation having biopurification activity
NL1015933A NL1015933C2 (nl) 1999-03-04 2000-08-14 Nieuw melkzuurbacteriÙnpreparaat met biozuiveringsactiviteit.
ES200002094A ES2168076B2 (es) 1999-03-04 2000-08-17 Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion.
FR0010769A FR2813084B1 (fr) 1999-03-04 2000-08-21 Preparation de bacteries lactiques ayant une activite de biopurification
CNB001262033A CN1160085C (zh) 1999-03-04 2000-08-24 具有生物净化活性的乳酸菌制剂
RU2000122386/13A RU2186575C2 (ru) 1999-03-04 2000-08-24 Новый препарат молочнокислых бактерий со свойствами биологической очистки (варианты)
BR0005049-0A BR0005049A (pt) 1999-03-04 2000-08-25 Novo preparado de bactéria de ácido lático tendo atividade de biopurificação
DE10042625A DE10042625A1 (de) 1999-03-04 2000-08-30 Milchsäurebakterien-Präparat mit Aktivität zur biologischen Reinigung

Publications (2)

Publication Number Publication Date
ES2168076A1 ES2168076A1 (es) 2002-05-16
ES2168076B2 true ES2168076B2 (es) 2004-01-01

Family

ID=27582835

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200002094A Expired - Fee Related ES2168076B2 (es) 1999-03-04 2000-08-17 Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion.

Country Status (12)

Country Link
US (1) US6333188B1 (es)
JP (1) JP4193269B2 (es)
CN (1) CN1160085C (es)
AU (1) AU4896600A (es)
BR (1) BR0005049A (es)
CA (1) CA2314775C (es)
DE (1) DE10042625A1 (es)
ES (1) ES2168076B2 (es)
FR (1) FR2813084B1 (es)
GB (1) GB2365444B (es)
NL (1) NL1015933C2 (es)
RU (1) RU2186575C2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4193269B2 (ja) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
KR100398665B1 (ko) * 2000-08-09 2003-09-19 비에이치피에이치 컴퍼니 리미티드 유산균 제제
JP4054697B2 (ja) * 2003-03-07 2008-02-27 株式会社アウレオ 便秘改善剤
CN1550545A (zh) * 2003-05-15 2004-12-01 肠球菌属乳酸菌以及乳酸菌死菌体的制造方法
JP2004357703A (ja) * 2003-05-15 2004-12-24 Yasuo Kawai エンテロコッカス属に属する乳酸菌の培養方法及びエンテロコッカス属に属する乳酸菌死菌体の製造方法
ZA200600866B (en) * 2003-07-30 2007-04-25 Bhph Company Ltd Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
JP5411405B2 (ja) * 2004-03-16 2014-02-12 コンビ株式会社 家畜・家禽用下痢抑制剤
US7465576B2 (en) * 2004-08-12 2008-12-16 Bhph Company Limited Method for treating periodontal disease with a bacteriocidal disinfectant
JP5592048B2 (ja) * 2006-06-30 2014-09-17 雪印メグミルク株式会社 乳酸菌の増殖促進剤および生残性向上剤
CA2660767A1 (en) * 2006-08-18 2008-02-21 Organobalance Gmbh Probiotic microorganisms for the reduction of manure odor
DE502007004849D1 (de) * 2007-02-02 2010-10-07 May Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
DE102015211640B4 (de) 2015-06-24 2017-09-21 Organon eG Frankfurt Stoff zum mikrobiologischen Behandeln von Gegenständen oder deren Oberflächen
EP3533861A1 (en) * 2018-03-02 2019-09-04 DuPont Nutrition Biosciences ApS Process for lyophilizing a microorganism
EP4074324A4 (en) * 2019-10-24 2024-02-28 Doctor TJ Co., Ltd. COMPOSITION CONTAINING ENTEROCOCUS FAECALIS AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF OBESITY OR METABOLIC SYNDROMES INDUCED THEREBY

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
JPS5548386A (en) 1979-06-18 1980-04-07 Seikenkai Novel mocroorganism and fecal matter deodorant
JPS55143916A (en) 1980-01-21 1980-11-10 Seikenkai Viable bacterium preparation
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
JPS63280027A (ja) * 1987-05-11 1988-11-17 Nichinichi Shokuhin Kk 抗高脂血症剤
WO1989011858A1 (en) * 1988-06-09 1989-12-14 Whitecliffe Laboratories Limited Treatment of immunodeficiency
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
RU2091075C1 (ru) * 1995-06-28 1997-09-27 Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Комплексный бактериальный препарат для лечения и профилактики желудочно-кишечных заболеваний животных
JPH10298083A (ja) * 1997-04-28 1998-11-10 Wakamoto Pharmaceut Co Ltd 高脂血症治療用組成物および高脂血症対応食品
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
JP2000217566A (ja) * 1999-01-25 2000-08-08 Bhph Co Ltd ラクトバチラスクリアランスを培養するための培養基および該菌種の保存方法
JP4193269B2 (ja) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤

Also Published As

Publication number Publication date
RU2186575C2 (ru) 2002-08-10
JP2000256202A (ja) 2000-09-19
US6333188B1 (en) 2001-12-25
CA2314775A1 (en) 2002-01-31
GB0018956D0 (en) 2000-09-20
CN1160085C (zh) 2004-08-04
CN1339301A (zh) 2002-03-13
NL1015933C2 (nl) 2002-02-18
AU4896600A (en) 2002-02-07
DE10042625A1 (de) 2002-03-28
ES2168076A1 (es) 2002-05-16
FR2813084A1 (fr) 2002-02-22
BR0005049A (pt) 2002-06-11
CA2314775C (en) 2006-11-28
GB2365444B (en) 2004-07-21
FR2813084B1 (fr) 2004-10-22
GB2365444A (en) 2002-02-20
JP4193269B2 (ja) 2008-12-10

Similar Documents

Publication Publication Date Title
ES2168076B2 (es) Nueva preparacion de bacterias de acido lactico con actividad de biopurificacion.
MX2007015217A (es) Sistema automatizado de terapia mediante celulas.
YU61799A (sh) Postupak za fermentacionu proizvodnju d-pantotenske kiseline pomoću pojačanja pan d-gena u mikroorganizmima
WO2005080544A3 (en) Cell/tissue culturing device, system and method
BRPI0408165A (pt) processos para melhorar a atividade das enzimas de degradação de lignocelulose
IL207268A0 (en) Methods of culture systems of preparing feeder cells - free, xeno - free human embryonic stem cells and stem cell cultures prepared using same
DK1082410T3 (da) Humane CD45 - og/eller fibroblast mesenchymale stamceller
AR032392A1 (es) Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
NZ603330A (en) Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
DE60020855D1 (de) Bedingte immortalisierung von zellen
MY176503A (en) Hypoglycemic effect enhancer
BR0001392A (pt) Meio sintético para o cultivo de lactobacillus e bifidobacteria
WO2001002548A3 (en) Methods for the propagation of lytic organisms
ES2142454T3 (es) Inhibicion de clostridia con bacterias de acido lactico.
ATE374038T1 (de) Verwendung von bakteriellen pard kis/pard kid toxin-antitoxin system zur tötung von eukaryotischen zellen
ES2085377T3 (es) Metodo de produccion de dextrano antitumoral.
DE60040548D1 (de) Mittel zur senkung von cholesterin, mittel zur hemmung der produktion von sekundären gallensäuren, nahrungsmittel und getränke
BR9908056A (pt) Utilização de um anticorpo para preparação de uma composição, composição, artigo absorvente descartável e processo para reduzir a atividade de enzimas presentes na pele externa
AR025062A1 (es) Preparacion de bacteria acido lactica que posee una actividad de biopurificacion
PL354747A1 (en) Modified ubiquitin regulatory system
WO2011129607A3 (en) Method for increasing stem cell activity and stem cells produced thereby
ES2176166T3 (es) Procedimiento para la separacion enzimatica de la lactosa, especialmente mediante reactores de difusion por membrana.
WO2012009538A3 (en) Adipocyte-derived membrane extract with biological activity

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2168076B2

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211117